Mahaney Paige — SEC Form 4 filings

SEC reporting owner CIK 2040313. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-10-29 to 2026-02-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
C4 Therapeutics, Inc. (CCCC)Chief Scientific Officer49

Form 4 filings — Mahaney Paige

FiledFormIssuerReported transactionsSource
2026-02-184C4 Therapeutics, Inc. (CCCC)Grant/award (A): 240,000 @ $0 · Option exercise (M): 7,050 @ $0 · Tax withholding (F): 2,446 @ $1.89EDGAR
2025-10-304C4 Therapeutics, Inc. (CCCC)Option exercise (M): 19,200 @ $0 · Tax withholding (F): 5,644 @ $2.58EDGAR
2025-02-184C4 Therapeutics, Inc. (CCCC)Grant/award (A): 28,200 @ $0 · Grant/award (A): 42,400 (derivative) @ $0EDGAR
2024-10-294C4 Therapeutics, Inc. (CCCC)Grant/award (A): 76,800 @ $0 · Grant/award (A): 345,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2040313 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →